HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients.

AbstractOBJECTIVE:
The conversion of Hashimoto's thyroiditis (HT) to hyperthyroidism due to thyrotropin receptor antibodies is intriguing and considered rare. The contribution of TSH receptor blocking antibodies (TRAb), which may be stimulators (TSAb) or blockers (TBAb), is suspected. We describe clinical and biological variables in a series of patients switching from Hashimoto's thyroiditis to Grave's disease.
SUBJECTS AND METHODS:
Retrospective case study of 24 patients with Hashimoto's thyroiditis followed during 48 ± 36 months that developed later Graves' disease (GD). These variables were analysed in the hypo and hyperthyroid phase: age, sex, initial TSH, free triiodothyronine (fT3), free thyroxine (fT4), anti-TPO, TBII antibodies, parietal cell autoantibodies, time between hypo and hyperthyroidism, thyroid volume and levothyroxine doses (LT).
RESULTS:
In HT, mean TSH was 9.4 ± 26.1 UI/L and levothyroxine treatment was 66.2 ± 30.8 µg/day. The switch to GD was observed 38 ± 45 months after HT diagnosis. As expected, we found significant differences on TSH, FT3, FT4 and TBAb levels. Three out of 14 patients had parietal cell autoantibodies. In two of these three cases there was an Helicobacter pylori infection. There were no significant differences between HT and GD groups with respect to thyroid volume.
CONCLUSIONS:
To our knowledge, large series documenting the conversion of HT to GD are scarce. Although rare, this phenomenon should not be misdiagnosed. Suspicion should be raised whenever thyroxine posology must be tapered down during the follow-up of HT patients. Further immunological and genetic studies are needed to explain this unusual autoimmune change.
AuthorsBeatriz Gonzalez-Aguilera, Daniela Betea, Laurence Lutteri, Etienne Cavalier, Vincent Geenen, Albert Beckers, Hernan Valdes-Socin
JournalArchives of endocrinology and metabolism (Arch Endocrinol Metab) Vol. 62 Issue 6 Pg. 609-614 ( 2018) ISSN: 2359-4292 [Electronic] Brazil
PMID30624501 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
  • Immunoglobulins, Thyroid-Stimulating
  • Receptors, Thyrotropin
  • thyrotropin-binding inhibitory immunoglobulin
  • Triiodothyronine
  • Thyrotropin
  • Thyroxine
Topics
  • Adult
  • Autoantibodies (immunology)
  • Female
  • Graves Disease (blood, immunology)
  • Hashimoto Disease (blood, immunology)
  • Humans
  • Hypothyroidism (immunology)
  • Immunoglobulins, Thyroid-Stimulating (blood, immunology)
  • Luminescent Measurements
  • Male
  • Middle Aged
  • Receptors, Thyrotropin (blood, immunology)
  • Retrospective Studies
  • Statistics, Nonparametric
  • Thyroid Function Tests
  • Thyrotropin (blood)
  • Thyroxine (administration & dosage, blood)
  • Triiodothyronine (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: